News Hemab raises $135m for rare bleeding disorder trials Cash will be used to advance drugs for Glanzmann thrombasthenia and von Willebrand disease.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
